Universal Ibogaine Inc. (TSXV:IBO)

Universal Ibogaine Balance Sheet

Financials in millions CAD. Fiscal year is August - July.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Cash & Equivalents	0.13	0.37	0.31	0.73	0.14	0.05
Short-Term Investments	-	-	-	-	-	0.04
Cash & Short-Term Investments	0.13	0.37	0.31	0.73	0.14	0.1
Cash Growth	-72.83%	18.37%	-56.85%	410.60%	49.68%	911.95%
Accounts Receivable	0.61	0.18	0.06	-	-	-
Other Receivables	-	0.02	0	0.23	0.11	0.03
Receivables	0.61	0.19	0.07	0.23	0.11	0.03
Prepaid Expenses	0.05	0.06	0.05	0.06	0.02	0.12
Other Current Assets	-	0.42	0.01	-	0.63	0.19
Total Current Assets	0.78	1.04	0.44	1.02	0.9	0.44
Property, Plant & Equipment	3.22	3.47	3.66	5.3	3.05	0.11
Long-Term Deferred Charges	-	-	-	-	0.04	-
Other Long-Term Assets	-	-	1.4	-	-	-
Total Assets	4.01	4.51	5.5	6.32	3.99	0.55

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Accounts Payable	0.12	0.22	0.3	0.17	0.3	0.3
Accrued Expenses	0.61	0.47	0.5	0.28	0.28	0.09
Short-Term Debt	-	-	1.8	1.56	0.35	0.61
Current Portion of Long-Term Debt	0.83	0.11	-	-	-	-
Current Portion of Leases	0.02	0.02	0.02	-	-	-
Current Unearned Revenue	0.39	0.14	0.11	-	-	-
Other Current Liabilities	0.04	0.05	0.07	0.18	0.06	0.04
Total Current Liabilities	2.01	1	2.79	2.19	0.99	1.05
Long-Term Debt	1.68	2.47	0.94	0.18	0.06	-
Long-Term Leases	0.04	0.06	0.02	-	-	-
Total Liabilities	3.73	3.52	3.75	2.37	1.05	1.05

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Common Stock	24.15	24.15	22.84	22.8	13.79	4.38
Additional Paid-In Capital	4.02	4.02	4.04	3.88	-	-
Retained Earnings	-27.9	-27.18	-25.13	-22.74	-12.25	-8.38
Comprehensive Income & Other	0.01	0.01	0.01	0.01	1.4	3.51
Shareholders' Equity	0.27	0.99	1.75	3.94	2.94	-0.49
Total Liabilities & Equity	4.01	4.51	5.5	6.32	3.99	0.55

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Total Debt	2.57	2.65	2.78	1.74	0.41	0.61
Net Cash (Debt)	-2.44	-2.28	-2.46	-1.01	-0.27	-0.51
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.01	-0.01	-0.01	-0.01	-0.00	-0.01
Filing Date Shares Outstanding	308.61	308.61	191.72	190.74	190.57	43.55
Total Common Shares Outstanding	308.61	308.61	191.72	190.74	131.09	43.55
Working Capital	-1.23	0.04	-2.34	-1.18	-0.09	-0.61
Book Value Per Share	0.00	0.00	0.01	0.02	0.02	-0.01
Tangible Book Value	0.27	0.99	1.75	3.94	2.94	-0.49
Tangible Book Value Per Share	0.00	0.00	0.01	0.02	0.02	-0.01
Land	0.35	0.35	0.35	3.35	3	-
Buildings	3.62	3.62	3.5	3.33	-	-
Machinery	0.35	0.35	0.31	0.23	0.16	0.16

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error